1978 - 1979 Intern, Internal Medicine University of Colorado Medical Center
1979 - 1981 Resident, Internal MedicineUniversity of Colorado Medical Center
1981 - 1982 Research Fellow National Jewish Hospital and Research Center
1982 - 1985 Fellow, Pulmonary Medicine University of Colorado Health Sciences Center
1971 - 1975 Radcliffe College, Harvard UniversityA.B., Biology (Magna cum laude)
1975 - 1978 University of Arizona M.D., College of Medicine
1985 - 1986 Instructor, Department of MedicineUniversity of Colorado Health Sciences Center
1986 - 1992 Assistant Professor, Department of MedicineUniversity of Colorado Health Sciences Center
1992 - 1999 Associate Professor, Department of MedicineUniversity of Colorado Health Sciences Center
1999-2000 Professor, Department of Medicine University of Colorado Health Sciences Center
2000-present Professor, Department of Medicine University of Vermont
2004 President, Association of Pulmonary and Critical Care Medicine Program Directors
2004 Chair, FDA Pulmonary-Allergy Drugs Advisory Committee
2006 American Thoracic Society Elizabeth A. Rich Award Recipient
2011-2015 NIH NHLBI Scientific Advisory Council Member
2013 American Thoracic Society Distinguished Achievement Award
2017 ATS Assembly on Critical Care 9th Annual Lifetime Achievement Award
2018 President, American Thoracic Society
2018 Parker B. Francis Foundation: Scientific Director, Fellowship Program
2018 Patriotic Employer Recognition from Office of the Secretary of Defense
2021 Edward Livingston Trudeau Medal
2021 Master, American College of Physicians
Coleman DL, Wardrop RM, Zeidel ML, Parsons PE. Strategies for Developing and Recognizing Faculty Working in Quality Improvement and Patient Safety. Academic Medicine Academic Medicine 92:52-57, 2017 (epub May 17, 2016) PMID 27191838
Ubags ND, Stapleton RD, Vernooy JH, Burg E, Bement J, Hayes CM, Zabeau L, Tavernier J, Wargo MJ, Littenberg B, Poynter ME, Wouters EF, Parsons PE, Dixon AE, Suratt BT; NHLBI Acute Respiratory Distress Syndrome Network. Hyperleptinemia is associated with impaired pulmonary host defense. JCI Insight 1:282101, 2016. PMID 27347561
Limay AP, Stapleton RD, PengL, Gunn SR, Kimball LE, Hyzy R, Exline MC, Files DC, Morris PE, Frankel SK, Mikkelsen ME, Hite D, Enfield KB, Steingrub J, O'Brien J, Parsons PE, Cuschieri J, Wunderink RG, Hotchkin DL, Chen YQ, Rubenfeld GD, Boeckh M. Effect of ganciclovir on IL-6 levels among cytomegalovirus-seropositive adults with critical illness: A randomized clinical trial. JAMA 318:731-740, 2017. PMID 2882987
Engelgau MM, Narayan KMV, Ezzati M, Salicrup LA, Belis D., Aron LY, Beaglehole R, Beaudet A, Briss PA, Chambers DA, Devaux M, Fiscella K, Gottlieb M, Hakkinen U, Henderson R, Hennis AJ, Hochman JS, Jan S, Koroshetz WJ, Mackenbach JP, Marmot MG, Martikainen P, McClellan M, Meyers D, Parsons PE, Rehnberg C, Sanghavi D, Sidney S, Siega-Riz A, Straus S, Woolf SH, Constant S, Creazzo TL, deJesus JM, Gavini N, Lerner NB, Mishoi HO, Nelson C, Peprah E, Punturieri A, Ucheckukwu S, Tracy RL, Mensah GA. Implementation research to address the United States health disadvantage: Report of a National Heart, Lung, and Blood Institute Workshop; Global Health (in press)
Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA and the NHLBI ARDS Network. Latent class analysis of ARDS subphenotypes: Analysis of data from two randomized controlled trials. Lancet Respiratory Medicine 2:611-20, 2014 (Epub 2014 May 19). PMID:24853585
To view more of Dr. Parsons' publications, please visit PubMed.